These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Integrated routine workflow using next-generation sequencing and a fully-automated platform for the detection of KRAS, NRAS and BRAF mutations in formalin-fixed paraffin embedded samples with poor DNA quality in patients with colorectal carcinoma. Franczak C; Dubouis L; Gilson P; Husson M; Rouyer M; Demange J; Leroux A; Merlin JL; Harlé A PLoS One; 2019; 14(2):e0212801. PubMed ID: 30811471 [TBL] [Abstract][Full Text] [Related]
5. Rapid BRAF mutation tests in patients with advanced melanoma: comparison of immunohistochemistry, Droplet Digital PCR, and the Idylla Mutation Platform. Bisschop C; Ter Elst A; Bosman LJ; Platteel I; Jalving M; van den Berg A; Diepstra A; van Hemel B; Diercks GFH; Hospers GAP; Schuuring E Melanoma Res; 2018 Apr; 28(2):96-104. PubMed ID: 29232304 [TBL] [Abstract][Full Text] [Related]
6. Prospective evaluation of two screening methods for molecular testing of metastatic melanoma: Diagnostic performance of BRAF V600E immunohistochemistry and of a NRAS-BRAF fully automated real-time PCR-based assay. Vallée A; Denis-Musquer M; Herbreteau G; Théoleyre S; Bossard C; Denis MG PLoS One; 2019; 14(8):e0221123. PubMed ID: 31415669 [TBL] [Abstract][Full Text] [Related]
7. Clinical performance evaluation of the Idylla NRAS-BRAF mutation test on retrospectively collected formalin-fixed paraffin-embedded colorectal cancer tissue. Johnston L; Power M; Sloan P; Long A; Silmon A; Chaffey B; Lisgo AJ; Little L; Vercauteren E; Steiniche T; Meyer T; Simpson J J Clin Pathol; 2018 Apr; 71(4):336-343. PubMed ID: 28899979 [TBL] [Abstract][Full Text] [Related]
8. The usefulness of a novel fully automated PCR-based Idylla test for detection of the BRAF V600E mutation in thyroid tissue: comparison with PNA-clamping PCR, real-time PCR and pyrosequencing. Yeo MK; Jung MK; Lee SY; Lee YM; Hur GM; Kim JM J Clin Pathol; 2017 Mar; 70(3):260-265. PubMed ID: 27543599 [TBL] [Abstract][Full Text] [Related]
11. Multisite analytic performance studies of a real-time polymerase chain reaction assay for the detection of BRAF V600E mutations in formalin-fixed, paraffin-embedded tissue specimens of malignant melanoma. Anderson S; Bloom KJ; Vallera DU; Rueschoff J; Meldrum C; Schilling R; Kovach B; Lee JR; Ochoa P; Langland R; Halait H; Lawrence HJ; Dugan MC Arch Pathol Lab Med; 2012 Nov; 136(11):1385-91. PubMed ID: 22332713 [TBL] [Abstract][Full Text] [Related]
12. BRAF Mutation Testing in Cell-Free DNA from the Plasma of Patients with Advanced Cancers Using a Rapid, Automated Molecular Diagnostics System. Janku F; Huang HJ; Claes B; Falchook GS; Fu S; Hong D; Ramzanali NM; Nitti G; Cabrilo G; Tsimberidou AM; Naing A; Piha-Paul SA; Wheler JJ; Karp DD; Holley VR; Zinner RG; Subbiah V; Luthra R; Kopetz S; Overman MJ; Kee BK; Patel S; Devogelaere B; Sablon E; Maertens G; Mills GB; Kurzrock R; Meric-Bernstam F Mol Cancer Ther; 2016 Jun; 15(6):1397-404. PubMed ID: 27207774 [TBL] [Abstract][Full Text] [Related]
13. Comparison of high resolution melting analysis, pyrosequencing, next generation sequencing and immunohistochemistry to conventional Sanger sequencing for the detection of p.V600E and non-p.V600E BRAF mutations. Ihle MA; Fassunke J; König K; Grünewald I; Schlaak M; Kreuzberg N; Tietze L; Schildhaus HU; Büttner R; Merkelbach-Bruse S BMC Cancer; 2014 Jan; 14():13. PubMed ID: 24410877 [TBL] [Abstract][Full Text] [Related]
14. KRAS and BRAF mutation analysis in routine molecular diagnostics: comparison of three testing methods on formalin-fixed, paraffin-embedded tumor-derived DNA. Heideman DA; Lurkin I; Doeleman M; Smit EF; Verheul HM; Meijer GA; Snijders PJ; Thunnissen E; Zwarthoff EC J Mol Diagn; 2012; 14(3):247-55. PubMed ID: 22425762 [TBL] [Abstract][Full Text] [Related]
15. Comparison of Five Different Assays for the Detection of BRAF Mutations in Formalin-Fixed Paraffin Embedded Tissues of Patients with Metastatic Melanoma. Franczak C; Salleron J; Dubois C; Filhine-Trésarrieu P; Leroux A; Merlin JL; Harlé A Mol Diagn Ther; 2017 Apr; 21(2):209-216. PubMed ID: 28130756 [TBL] [Abstract][Full Text] [Related]
16. Rapid clinical mutational testing of Van Haele M; Vander Borght S; Ceulemans A; Wieërs M; Metsu S; Sagaert X; Weynand B J Clin Pathol; 2020 Jan; 73(1):35-41. PubMed ID: 31296605 [TBL] [Abstract][Full Text] [Related]
18. Analytical performance of a real-time PCR-based assay for V600 mutations in the BRAF gene, used as the companion diagnostic test for the novel BRAF inhibitor vemurafenib in metastatic melanoma. Halait H; Demartin K; Shah S; Soviero S; Langland R; Cheng S; Hillman G; Wu L; Lawrence HJ Diagn Mol Pathol; 2012 Mar; 21(1):1-8. PubMed ID: 22306669 [TBL] [Abstract][Full Text] [Related]
19. Multicenter Evaluation of the Idylla NRAS-BRAF Mutation Test in Metastatic Colorectal Cancer. Prieto-Potin I; Montagut C; Bellosillo B; Evans M; Smith M; Melchior L; Reiltin W; Bennett M; Pennati V; Castiglione F; Bürrig KF; Cooper U; Dockhorn-Dworniczak B; Rossenbach C; Luna-Aguirre CM; Barrera-Saldaña HA; Machado JC; Costa JL; Yacobi R; Tabibian-Keissar H; Buglioni S; Ronchetti L; Douglas-Berger L; Dubbink HJ; Alorini M; Sabourin JC; Rojo F J Mol Diagn; 2018 Sep; 20(5):664-676. PubMed ID: 29959022 [TBL] [Abstract][Full Text] [Related]
20. Multicenter Evaluation of the Fully Automated PCR-Based Idylla EGFR Mutation Assay on Formalin-Fixed, Paraffin-Embedded Tissue of Human Lung Cancer. Evrard SM; Taranchon-Clermont E; Rouquette I; Murray S; Dintner S; Nam-Apostolopoulos YC; Bellosillo B; Varela-Rodriguez M; Nadal E; Wiedorn KH; Melchior L; Andrew E; Jones M; Ridgway J; Frykman C; Lind L; Rot M; Kern I; Speel EJM; Roemen GMJM; Trincheri N; Freiberger SN; Rechsteiner M J Mol Diagn; 2019 Nov; 21(6):1010-1024. PubMed ID: 31445213 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]